These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 594661)

  • 1. An inhibitor of activated factor XIII, inhibiting fibrin cross-linking but not incorporation of amine into casein.
    Godal HC; Ly B
    Scand J Haematol; 1977 Nov; 19(5):443-8. PubMed ID: 594661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A unique factor XIII inhibitor to a fibrin-binding site on factor XIIIA.
    Fukue H; Anderson K; McPhedran P; Clyne L; McDonagh J
    Blood; 1992 Jan; 79(1):65-74. PubMed ID: 1370210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An acquired inhibitor of factor XIII with a qualitative abnormality of fibrin cross-linking.
    Fear JD; Miloszewski KJ; Losowsky MS
    Acta Haematol; 1984; 71(5):304-9. PubMed ID: 6429995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gly-Pro-Arg-Pro modifies the glutamine residues in the alpha- and gamma-chains of fibrinogen: inhibition of transglutaminase cross-linking.
    Achyuthan KE; Dobson JV; Greenberg CS
    Biochim Biophys Acta; 1986 Aug; 872(3):261-8. PubMed ID: 2873839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and genetic studies on fibrin-stabilizing factor with a new assay based on amine incorporation.
    Lorand L; Urayama T; De Kiewiet JW; Nossel HL
    J Clin Invest; 1969 Jun; 48(6):1054-64. PubMed ID: 4977030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of factor XIII activation by an anti-peptide monoclonal antibody.
    Lukacova D; Matsueda GR; Haber E; Reed GL
    Biochemistry; 1991 Oct; 30(42):10164-70. PubMed ID: 1681898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The activation of plasma factor XIII with the snake venom enzymes ancrod and batroxobin marajoensis.
    Walter M; Nyman D; Krajnc V; Duckert F
    Thromb Haemost; 1977 Aug; 38(2):438-46. PubMed ID: 579487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A monoclonal antibody against a peptide sequence of fibrinogen gamma chain acts as an inhibitor of factor XIII-mediated crosslinking of human fibrin.
    Taubenfeld SM; Song Y; Sheng D; Ball EL; Matsueda GR
    Thromb Haemost; 1995 Sep; 74(3):923-7. PubMed ID: 8571322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of factor XIIIa (active fibrin-stabilizing factor) in normal plasma.
    Nelson JC; Lerner RG
    Blood; 1978 Sep; 52(3):581-91. PubMed ID: 678674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor XIII-mediated cross-linking of NH2-terminal peptide of alpha 2-plasmin inhibitor to fibrin.
    Ichinose A; Tamaki T; Aoki N
    FEBS Lett; 1983 Mar; 153(2):369-71. PubMed ID: 6617867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An inhibitor to fibrin stabilizing factor (FSF, factor XIII).
    Godal HC
    Scand J Haematol; 1970; 7(1):43-8. PubMed ID: 5447956
    [No Abstract]   [Full Text] [Related]  

  • 12. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
    Greenberg CS; Miraglia CC; Rickles FR; Shuman MA
    J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune antibody (IgG Kansas) against the fibrin stabilizing factor (factor XIII) system.
    Lorand L; Velasco PT; Rinne JR; Amare M; Miller LK; Zucker ML
    Proc Natl Acad Sci U S A; 1988 Jan; 85(1):232-6. PubMed ID: 3422419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin.
    Siebenlist KR; Meh DA; Mosesson MW
    Thromb Haemost; 2001 Nov; 86(5):1221-8. PubMed ID: 11816711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracerebral haemorrhage due to acquired factor XIII inhibitor--successful response to factor XIII concentrate.
    Daly HM; Carson PJ; Smith JK
    Blood Coagul Fibrinolysis; 1991 Aug; 2(4):507-14. PubMed ID: 1768763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid formation of large molecular weight alpha-polymers in cross-linked fibrin induced by high factor XIII concentrations. Role of platelet factor XIII.
    Francis CW; Marder VJ
    J Clin Invest; 1987 Nov; 80(5):1459-65. PubMed ID: 3680507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the cross-linking patterns of lamprey fibrinogen and fibrin by the action of the intrinsic lamprey factor XIII and human factor XIII during the process of blood coagulation.
    Murtaugh PA
    Thromb Haemost; 1977 Aug; 38(2):429-37. PubMed ID: 579486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation and mechanism of action of a potent inhibitor of factor XIII function.
    Reed GL; Lukacova D
    Thromb Haemost; 1995 Aug; 74(2):680-5. PubMed ID: 8585006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinogen-fibrin degradation products and factor XIII.
    Miloszewski K; Sheltawy MJ; Losowsky MS
    Acta Haematol; 1974; 51(6):321-30. PubMed ID: 4212013
    [No Abstract]   [Full Text] [Related]  

  • 20. A microtiter plate assay for factor XIII A-chain-fibrin interactions.
    Achyuthan KE; Santiago MA; Greenberg CS
    Anal Biochem; 1994 May; 219(1):43-8. PubMed ID: 8059954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.